These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL. Deng L; Li XL; Ye DS; Blockeel C; Zhou XY; Chen SL; Chen X Curr Med Sci; 2019 Apr; 39(2):278-284. PubMed ID: 31016522 [TBL] [Abstract][Full Text] [Related]
19. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Martin V; Wernke S; Mandell K; Zoma W; Bean J; Pinney S; Liu J; Ramadan N; Rebar R Headache; 2003 Apr; 43(4):309-21. PubMed ID: 12656701 [TBL] [Abstract][Full Text] [Related]
20. Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in vitro fertilization. Kaye L; Griffin D; Thorne J; Neuber E; Nulsen J; Benadiva C; Engmann L Fertil Steril; 2019 Sep; 112(3):534-544. PubMed ID: 31227286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]